Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
[Sociological research in Samara Oblast: a role of social organizations of patients in the improvement of quality of medical and social care].
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
Bilateral Vision Loss Responsive to Corticosteroids.
Viruses and Multiple Sclerosis.
Spinal cord injury is related to an increased risk of multiple sclerosis: a population-based, propensity score-matched, longitudinal follow-up study.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).
Mimics and chameleons of optic neuritis.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Activated microglia enhance neurogenesis via trypsinogen secretion.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Schwann cells in therapy of spinal cord injuries.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
The axes of access--improving care for patients with disabilities.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Early recognition and diagnosis of multiple sclerosis.
Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Pages
« first
‹ previous
…
217
218
219
220
221
222
223
224
225
…
next ›
last »